期刊文献+

天山雪莲愈伤组织提取物对人成骨肉瘤细胞MG-63增殖及分化的影响 被引量:4

Effectofextract from callus of Saussurea in volucrate on proliferation and differentiation of osteosarcoma cell MG-63
原文传递
导出
摘要 目的研究天山雪莲愈伤组织提取物(extract from callus of Saussureainvolucrate,ESI)对人成骨肉瘤细胞MG-63增殖及分化的影响,探讨ESI抗骨质疏松的作用及机制。方法以MG-63为研究对象,采用MTT法和乳酸脱氢酶(LDH)法检测ESI对成骨细胞增殖的影响,相关试剂盒检测碱性磷酸酶(ALP)活性和羟脯氨酸(Hyp)水平,茜素红染色法观察对矿化骨结节形成的影响;实时荧光定量PCR(RT-PCR)检测骨保护素(OPG)和核因子-κB活化因子受体配体(RANKL)基因表达水平;Western blotting法检测OPG/RANKL蛋白水平;检测p38特异性抑制剂SB203580对ESI作用于成骨细胞增殖、分化、矿化以及OPG/RANKL表达的影响。结果 ESI低于125μg/mL对成骨细胞无细胞毒性,31.25、62.5μg/mL对成骨细胞生长有促进作用;ESI显著提高ALP活性、Hyp水平以及矿化骨结节形成;显著上调MG-63细胞OPG mR NA水平,下调RANKLmR NA水平,上调OPG/RANKL蛋白水平;SB203580显著抑制ESI对成骨细胞增殖、ALP活性、矿化结节形成的促进作用以及对胶原蛋白积累量和OPG/RANKL值的提高作用。结论 ESI能够促进成骨细胞增殖、分化和矿化,其机制可能与调节OPG和RANKL基因表达有关,并且可能通过p38丝裂原活化蛋白激酶(MAPK)通路进行信号转导。 Objective To investigate the effect of extract from callus of Saussureainvolucrate(ESI) on the proliferation and differentiation of osteosarcoma cells MG-63 and explore its anti-osteoporosis and mechanism. Methods Using human osteosarcoma cells MG-63 for the study, the effect of ESI on the proliferation was detected by MTT and LDH methods;The activity of alkaline phosphatase activity(ALP) and the level of hydroxyproline(Hyp) were investigated by related reagent kit; The effect of ESI on mineralized nodules was observed by Alizarin red staining and quantified by CPC, the expression of OPG/RANKL was measured by RT-PCR and Western blotting, and the proliferation, differentiation, mineralization, and OPG/RANKL expression levels of MG-63 were assayed when medium contains both p38 inhibitor SB203580 and ESI. Results MTT and LDH assay showed that ESI(125μg/mL) was non-toxic to MG-63, and it promoted the proliferation at the concentration of 31.25 and 62.5μg/mL; ESI could significantly increase the ALP activity, Hyp content, and amount of mineralized nodules; At the mR NA level, ESIcould significantly up-regulate OPG expression and down-regulate RANKL expression; At the protein level, ESI could significantly increase the ratio ofO PG/RANKL; SB203580 could reverse the acceleration of ESI on the proliferation, differentiation, mineralization, and OPG/RANKL expression of MG-63. ConclusionE SI has the facilitating effect on the osteoblast proliferation, differentiation, and mineralization;The mechanism may be associated with the expression of OPG and RANKL, as well as the signaltransduction pathway of p38 Mitogen-activated potein kinase(MAPK).
出处 《中草药》 CAS CSCD 北大核心 2015年第19期2900-2907,共8页 Chinese Traditional and Herbal Drugs
关键词 天山雪莲 愈伤组织 成骨细胞 I型胶原蛋白 骨保护素 核因子-κB活化因子受体配体 p38丝裂原活化蛋白激酶 Saussureainvolucrata(Kar.et Kir.)Sch.-Bip. callus osteoblast typeI collagen protein osteoprotegerin RANKL p38 MAPK
  • 相关文献

参考文献19

  • 1中国药典[S].2010年版.一部.39-40,189,32.
  • 2Lo Y C, Chang Y H, Wei B L, et al. Betulinic acid stimulates the differentiation and mineralization of osteoblastic MC3T3-E1 cells: involvement of BMP/Runx2 and D-catenin signals [J]. Agric Food Chem, 2010, 58(11): 6643-6649.
  • 3Jiang S D, Yang Y H, Chen J W, et al. Isolated osteoblasts from spinal cord-injured rats respond less to mechanical loading as compared with those from hindlimb- immobilized rats [J]. Spinal Cord Med, 2013, 36(3): 220-224.
  • 4Niu Y B, Li Y H, Kong X H, et al. The beneficial effect of Radix dipsaci total saponins on bone metabolism in vitro and in vivo and the possible mechanisms of action [J]. Osteoporos Int, 2012, 23(11): 2649-2660.
  • 5Lewiecki E M. New targets for intervention in the treatment of postmenopausal osteoporosis [J]. Nat Rev Rheumatol, 2011, 7(11): 631-638.
  • 6樊秦,赵文君,李应东.华中五味子含药血清对成骨细胞增殖分化的影响[J].中国实验方剂学杂志,2009,15(2):33-35. 被引量:10
  • 7Miyamoto S, Miyamoto , Shibata Y, et al. In situ quasi-static and dynamic nanoindentation tests on calcified nodules formed by osteoblasts: Implication of glucocorticoids responsible for osteoblast calcification [J]. Acta Biomaterialia, 2015, 12(15): 216-226.
  • 8Cho Y E, Alcantara E H, Kuinaran S, et al. Red yeast rice stimulates osteoblast proliferation and increases alkaline phosphatase activity in MC3T3-E1 cells [J]. Nutr Res, 2010, 30(7): 501-510.
  • 9Harada S, Rodan G A. Control of osteoblast function and regulation of bone mass [J]. Nature, 2003, 423(6937): 349-355.
  • 10Li B, Ling Chau J F, Wang X, et al. Bisphosphonates, specific inhibitors of osteoclast function and a class of drugs for osteoporosis therapy [J]. Cell Biochem, 2011, 112(5): 1229-1242.

二级参考文献34

  • 1袁晓凡,赵兵,王玉春.雪莲的研究进展[J].中草药,2004,35(12):1424-1426. 被引量:59
  • 2王前,钟世镇,龚文汇,欧阳钧.鼠颅盖骨成骨细胞体外培养及ALP免疫组化法鉴别纯化[J].中华骨科杂志,1995,15(6):364-366. 被引量:32
  • 3杨伟鹏,林娜,刘春芳,周钟鸣,付春祥,赵德修.水母雪莲总黄酮和水母雪莲细胞培养物总黄酮对致炎大鼠血清中炎性因子的影响[J].中国实验方剂学杂志,2005,11(6):39-41. 被引量:14
  • 4Riggs BL. Melton LJ. involutional osteoporosis. N EngL J [ J]. Med, 1986,314 : 1676-1686.
  • 5Leoug WF, Zhou T, Lim GL, et al. Protein palmitoylation regulates osteoblast differentiation through BMP induced osterix expression. PLoS One, 2009; 4(1): e4135.
  • 6Lee JH, Kim BG, Ahn JM, et al. Role of PI3K on the regulation of BMP2 -induced betaCatenin activation in human bone marrow stern cells Bone, 2010; 46(6) : 1522-1532.
  • 7Hay E, Nouraud A, Marie PJ. N cadherin negatively regulates osteoblast proliferation and survival by antagonizing Wnt, ERK and PI3K/Akt signalling. PI~S One, 2009; 4(12):e8284.
  • 8Boyce BF, Xing L. Biology of RANK, RANKL, and osteoprotegerin. Arthritis Res Ther,2007,9 Supp| 1 :S1.
  • 9Wright HL, McCarthy HS, Middleton J, et al. RANK, RANKL and osteoprotegerin in bone biology and disease. Curr Rev Musculoskelet Med ,2009,2( 1 ) :56-64.
  • 10LeeSH,Rho J, Jeong D, et al. v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation. Nat Med ,2006,12 ( 12 ) : 1403-1409.

共引文献947

同被引文献143

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部